TRIB — Trinity Biotech Share News
0.000.00%
Last trade - 00:00- $5.11m
- $137.96m
- $43.79m
Brief: Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Minimum Bid Price Requirement
Brief: Trinity Biotech Announces The $30 Million Sale Of Its Life Sciences Supply Business To Biosynth
Brief: Trinity Biotech Files Prospectus Relates To Resale Of Up To 2.5 Mln Shares
Brief: Trinity Biotech Announces Fourth Quarter And Fiscal Year 2022 Financial Results
Brief: Trinity Biotech Welcomes Trinscreen Hiv's Inclusion In New Kenyan Hiv Testing Algorithm
Brief: Trinity Biotech Announces Strategic Partnership With Imaware
Brief: Trinity Biotech Announces Q3 2022 Financial Results
Brief: Trinity Biotech Reports Quarterly Total Revenues Of $18.5 Million
Brief: Trinity Biotech Announces The Appointment Of Tom Lindsay To Its Board
Brief: Trinity Biotech Announces The Appointment Of Aris Kekedjian As Chairman And CEO
Trinity Biotech PLC reports results for the quarter ended in March - Earnings Summary
Brief: Trinity Biotech Announces Q1 2022 Financial Results
Trinity Biotech PLC expected to post a loss of 4 cents a share - Earnings Preview
Trinity Biotech PLC expected to post a loss of 4 cents a share - Earnings Preview
Trinity Biotech PLC expected to post a loss of 4 cents a share - Earnings Preview
Trinity Biotech PLC expected to post a loss of 4 cents a share - Earnings Preview
Trinity Biotech PLC reports results for the quarter ended in December - Earnings Summary
Brief: Trinity Biotech Reports $45 Mln Strategic Investment And Partnership With The MiCo Group of South Korea
Brief: Trinity Biotech Announces Q4 And Fiscal Year 2021 Financial Results